Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.915
+0.035 (3.99%)
Dec 20, 2024, 4:00 PM EST - Market closed

Cytosorbents Revenue

Cytosorbents had revenue of $9.39M in the quarter ending September 30, 2024, with 6.58% growth. This brings the company's revenue in the last twelve months to $37.74M, up 1.80% year-over-year. In the year 2023, Cytosorbents had annual revenue of $36.35M with 4.79% growth.

Revenue (ttm)
$37.74M
Revenue Growth
+1.80%
P/S Ratio
1.27
Revenue / Employee
$202,901
Employees
186
Market Cap
50.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.35M1.66M4.79%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 202041.00M16.06M64.35%
Dec 31, 201924.95M2.45M10.87%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spero Therapeutics 106.46M
SHL Telemedicine 55.94M
Celularity 48.20M
iCAD, Inc. 18.94M
Dyadic International 3.36M
Singular Genomics Systems 2.67M
Exicure 500.00K
Revenue Rankings